It is widely accepted that antibody responses against the human parasitic pathogen Plasmodium falciparum protect the host from the rigors of severe malaria and death. However, there is a continuing need for the development of in vitro correlate assays of immune protection. To this end, the capacity of human monoclonal and polyclonal antibodies in eliciting phagocytosis and parasite growth inhibition via Fc␥ receptor-dependent mechanisms was explored. In examining the extent to which sequence diversity in merozoite surface protein 2 (MSP2) results in the evasion of antibody responses, an unexpectedly high level of heterologous function was measured for allele-specific human antibodies. The dependence on Fc␥ receptors for opsonic phagocytosis and monocyte-mediated antibody-dependent parasite inhibition was demonstrated by the mutation of the Fc domain of monoclonal antibodies against both MSP2 and a novel vaccine candidate, peptide 27 from the gene PFF0165c. The described flow cytometry-based functional assays are expected to be useful for assessing immunity in naturally infected and vaccinated individuals and for prioritizing among blood-stage antigens for inclusion in blood-stage vaccines.Merozoite surface protein 2 (MSP2) is a leading Plasmodium falciparum vaccine candidate. Antibody responses to MSP2 have been associated with protection from malaria in humans (1,11,37,43,50,53) and afford protection in mouse models (35,46). However, extreme sequence diversity in MSP2 is considered an obstacle for vaccine design. Hundreds of alleles encoding MSP2 are classified into two main allelic families represented by the 3D7 and FC27/D10 MSP2 sequences (15,28,49,57). The coexistence of parasites bearing the dimorphic alleles at similar frequencies in globally disparate locations indicates their maintenance by selective pressures (9). Given that MSP2 is a blood-stage antigen, it is considered likely that sequence diversification may be driven by the host immune response by allele-specific antibodies. Consistent with this hypothesis, vaccine recipients in the Combination B phase IIb vaccine trial, whose humoral responses against the MSP2-3D7 allele were boosted, were rendered more susceptible than the placebo controls to parasitization with heterologous FC27-type parasites (16,19). Early studies showed that mouse monoclonal antibodies (MAbs) that discriminated between heterologous parasites affected homologous in vitro growth inhibition (7, 13). Curiously, there is scant evidence of the inability of allele-specific MAbs to inhibit heterologous parasites in vitro (45).Like other P. falciparum antigens, MSP2 antibody responses are skewed to cytophilic (IgG1 and IgG3) isotypes (37,43,50,53,54), which have been positively associated with protection from malaria (4,11,21,37,44,50,54). These isotypes bind via their Fc domain to Fc␥ receptors, thereby eliciting cellular immune responses of the innate immune system. Antibody opsonization of P. falciparum-infected erythrocytes and merozoites enhances their phagocytosis (6,12,22,30,3...